New York, USA, April 11, 2022 (GLOBE NEWSWIRE) -- Atherectomy Devices Market Size is Anticipated to Progress at a Significant CAGR of 9.24% During the Study Period, Assesses DelveInsight
The Atherectomy Devices market size is expected to boost due to several factors such as rising geriatric population, rising prevalence of cardiovascular diseases, growing prevalence of lifestyle disorders such as hypertension and diabetes, and innovation in product development, among others.
DelveInsight's Atherectomy Devices Market Insights report provides the current and forecast market, upcoming device innovation, individual leading companies market shares, challenges, market drivers, barriers, and trends, and key Atherectomy Devices companies in the market.
Key Takeaways from the Atherectomy Devices Market Report
- According to DelveInsight analysis, North America is anticipated to dominate the global Atherectomy Devices market during the forecast period.
- The leading Atherectomy Devices companies with various types of Atherectomy Devices in various stages of development such as Koninklijke Philips N.V., Medtronic, Boston Scientific Corporation, AngioDynamics Inc, Cardiovascular Systems Inc, Avinger, BD, Ra Medical Systems, REX Medical, and others are currently working in the Atherectomy Devices market.
- As per DelveInsight analysis, the global Atherectomy Devices market size is expected to reach USD 1.46 billion by 2026.
- In January 2021, Cardiovascular Systems Inc received the CE mark for their Diamondback 360 Coronary Orbital Atherectomy System (OAS). The device is equipped with CSI’s GlideAssist which allows for easier removal, tracking, and smoother repositioning of the device.
- In May 2021, Koninklijke Philips N.V introduced the new Philips Laser System for peripheral and coronary atherectomy procedures.
- In September 2020, AngioDynamics announced the commercial launch of their Auryon Atherectomy System in the United States. The device is based on solid-state laser technology.
Interested in knowing how the Atherectomy Devices market size will be growing by 2026? Click to get a snapshot of Atherectomy Devices Market Growth Analysis
Atherectomy Devices
Atherectomy devices are medical devices that help in plaque removal from peripheral as well as coronary vasculature by cutting, shaving, sanding, or vaporizing the plaque deposits. There are four types of atherectomy devices: orbital atherectomy devices, rotational atherectomy devices, laser atherectomy devices, and directional atherectomy devices.
In 1991, directional coronary atherectomy devices became the first non balloon technique to get FDA approval. Directional Coronary Atherectomy devices remove tissue from the coronary artery, thereby "debulking" the region of stenosis, by inflating a low-pressure balloon on one side of the metal housing, which drives tissue into an elliptical aperture on the other side of the housing.
The possible coronary atherectomy risks include bleeding, which can be serious in some situations, bruising at the site of the incision, coronary artery damage, tears, or perforation which happens at a rate of roughly 3% and may necessitate emergency surgery.
Atherectomy Devices Market Insights
North America is expected to account for the greatest proportion of the Atherectomy Devices market among all other regions. Because of the importance of key growth factors such as the rising prevalence of cardiovascular diseases such as coronary heart disease, peripheral arterial disease, rising prevalence of obesity, hypertension, and diabetes, and the rising aging population, as well as rising government initiatives regarding disease treatment awareness, the North American Atherectomy Devices market is expected to grow positively.
In addition to the factors listed above, the growing interest of Atherectomy Device manufacturers in the region serves to improve regional product demand. For instance, in July 2020, BD purchased Straub Medical AG, a privately held firm that develops medical Atherectomy and thrombectomy devices to treat peripheral artery disease and venous disease. Such methods assist manufacturers in acquiring Atherectomy Devices market share as well as benefit end-users in terms of better product pricing from a competitive aspect, consequently propelling the Atherectomy Devices market ahead during the forecasted period.
To know more why North America is leading the market growth in the Atherectomy Devices market, get a snapshot of the report Global Atherectomy Devices Market Outlook
Atherectomy Devices Market Dynamics
The Atherectomy devices market is witnessing increased product demand due to various factors, one of which is the rising incidence of cardiovascular disorders. Moreover, another key factor that is aiding in the growth of Atherectomy devices is the growing demand for minimally invasive devices and procedures. Furthermore, product development developments such as the development of wearable Atherectomy devices are likely to contribute to the expansion of the global Atherectomy Devices market growth.
However, significant capital investments in laser-related Atherectomy devices, as well as Atherectomy procedure-related concerns such as the increased risk of distal embolization and arterial perforation, may limit the Atherectomy Devices market growth.
Get a sneak peek at the Atherectomy Devices market dynamics @ Atherectomy Devices Market Dynamics Analysis
Scope of the Atherectomy Devices Market Report
- Coverage: Global
- Study Period: 2018-2026
- Market Segmentation By Product Type - Directional Atherectomy Devices, Rotational Atherectomy Devices, Photoablative Atherectomy Devices, and Orbital Atherectomy Devices
- Market Segmentation By End-User - Hospitals, Specialty Clinics, and Others
- Market Segmentation By Geography - North America, Europe, Asia-Pacific, and Rest of World
- Key Atherectomy Devices Companies - Koninklijke Philips N.V., Medtronic, Boston Scientific Corporation, AngioDynamics Inc, Cardiovascular Systems Inc, Avinger, BD, Ra Medical Systems, REX Medical, among others
- Porter’s Five Forces Analysis, Product Profiles, Case Studies, KOL's Views, Analyst's View
DelveInsight Analysis: The Atherectomy Devices market size is expected to grow at a CAGR of 9.24% during the forecast period from 2021 to 2026 to reach USD 1.46 billion by 2026.
Which MedTech key players in the Atherectomy Devices market are set to emerge as the trendsetter explore @ Atherectomy Devices Companies
Table of Contents
| 1 | Atherectomy Devices Market Report Introduction |
| 2 | Atherectomy Devices Market Executive summary |
| 3 | Regulatory and Patent Analysis |
| 4 | Atherectomy Devices Market Key Factors Analysis |
| 5 | Porter’s Five Forces Analysis |
| 6 | COVID-19 Impact Analysis on Atherectomy Devices Market |
| 7 | Atherectomy Devices Market Layout |
| 8 | Atherectomy Devices Global Company Share Analysis – Key 3-5 Companies |
| 9 | Atherectomy Devices Market Company and Product Profiles |
| 10 | Project Approach |
Learn more about the different atherectomy devices @ Best Atherectomy Device
Related Reports
Hypertension Pipeline Insight, 2022 report provides comprehensive insights about the pipeline landscape. It covers the pipeline drug profiles, including clinical and non-clinical stage products along with the Hypertension companies such as Merck Sharp & Dohme, Acceleron Pharma, Liquidia Technologies, Gossamer Bio, among others.
Atherosclerosis Pipeline Insight, 2022 report provides comprehensive insights about the pipeline landscape. It covers the pipeline drug profiles, including clinical and non-clinical stage products along with the Atherosclerosis companies such as Regeneron, Sanofi, Immunitor, Novartis, MedImmune, among others.
Diabetes Market Insight, Epidemiology, and Market Forecast, 2032 report delivers an in-depth understanding of market trends, market drivers, market barriers, along with emerging drugs and key Diabetes companies such as Daewoong Tradipitant, Janssen Biotech, Zealand Pharma, Provention Bio, among others.
Diabetes Insipidus Market Insight, Epidemiology, and Market Forecast, 2032 report delivers an in-depth understanding of market trends, market drivers, market barriers, and key Diabetes Insipidus companies such as Daewoong Tradipitant, Janssen Biotech, Zealand Pharma, Provention Bio, among others.
Peripheral Vascular Devices Market
Peripheral Vascular Devices Market Insight, Competitive Landscape, and Market Forecast, 2026 report delivers an in-depth understanding of market trends, market drivers, market barriers, and key Peripheral Vascular Devices companies such as Medtronic, Boston Scientific Corporation, B. Braun Melsungen AG, Braile Biomedica, JOTEC GmbH, Edwards LifeSciences Corporation, among others.
Peripheral Vascular Clot Management Interventions Market
Peripheral Vascular Clot Management Interventions Market Insight, Competitive Landscape, and Market Forecast, 2026 report delivers an in-depth understanding of market trends, market drivers, market barriers, and key Peripheral Vascular Clot Management Interventions companies such as Boston Scientific Corporation, Penumbra Inc, Medtronic, Koninklijke Philips N.V., Edward LifeSciences Corporation, Cardinal Health, among others.
Other Trending Reports
Follicular Lymphoma Market Insight, Epidemiology, and Market Forecast, 2032 report delivers an in-depth understanding of market trends, market drivers, market barriers, along with emerging drugs and key Follicular Lymphoma companies such as Merck & Co, Genentech, Incyte Corporation, Syndax Pharmaceuticals, among others.
Renal Vasculitis Market Insight, Epidemiology, and Market Forecast, 2032 report delivers an in-depth understanding of market trends, market drivers, market barriers, along with emerging drugs and key Renal Vasculitis companies operating in the domain.
Erectile Dysfunction Market Insight, Epidemiology, and Market Forecast, 2032 report delivers an in-depth understanding of market trends, market drivers, market barriers, along with emerging drugs and key Erectile Dysfunction companies such as Sumitovant Biopharma, Ildong Pharmaceutical, Aquestive Therapeutics, among others.
Erectile Dysfunction Devices Market
Erectile Dysfunction Devices Market Insight, Competitive Landscape, and Market Forecast, 2026 report delivers an in-depth understanding of market trends, market drivers, market barriers, and key Erectile Dysfunction Devices companies such as Coloplast Corporation, Zimmer Aesthetics, Augusta Medical Systems, Medispec Ltd., MTS Medical UG, among others.
Cancer Pain Market Insight, Epidemiology, and Market Forecast, 2032 report delivers an in-depth understanding of market trends, market drivers, market barriers, and key Cancer Pain companies such as vTv Therapeutics, AstraZeneca, Janssen, among others.
Chronic Phase Chronic Myeloid Leukemia Market
Chronic Phase Chronic Myeloid Leukemia Market Insight, Epidemiology, and Market Forecast, 2032 report delivers an in-depth understanding of market trends, market drivers, market barriers, and key Chronic Phase Chronic Myeloid Leukemia companies such as Bristol-Myers Squibb, AOP Orphan Pharmaceuticals, Medical College of Wisconsin, Chia Tai Tianqing Pharmaceutical, among others.
Hormone Sensitive Advanced Prostate Cancer Market
Hormone Sensitive Advanced Prostate Cancer Market Insight, Epidemiology, and Market Forecast, 2032 report delivers an in-depth understanding of market trends, market drivers, market barriers, and key Hormone Sensitive Advanced Prostate Cancer companies such as Ferring Pharmaceuticals, among others.
Related Healthcare Blogs
Upcoming Cardiovascular Disease Drugs
Leading Companies in Cardiology Market
About DelveInsight
DelveInsight is a leading Business Consultant, and Market Research firm focused exclusively on life sciences. It supports Pharma companies by providing comprehensive end-to-end solutions to improve their performance.
